Stockreport

Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD [Yahoo! Finance]

Cencora, Inc.  (COR) 
Last cencora, inc. earnings: 4/30 06:30 am Check Earnings Report
US:NYSE Investor Relations: investors.coresite.com/investor-overview
PDF European Commission decision applies automatically to all 27 EU Member States and, within 30 days, also to Iceland, Norway and Liechtenstein LYTENAVA™ (bevacizumab ga [Read more]